Cargando…

Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas

Introduction: Mucosal melanoma is rare and associated with poorer prognosis in comparison to conventional melanoma subtypes. Little is known about the prognostic significance as well as possible associations between PARP1 and immunologic response in mucosal melanoma. Methods: PARP1, PD-L1 and IDO1 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donizy, Piotr, Wu, Cheng-Lin, Mull, Jason, Fujimoto, Masakazu, Chłopik, Agata, Peng, Yan, Shalin, Sara C., Selim, M. Angelica, Puig, Susana, Fernandez-Figueras, Maria-Teresa, Shea, Christopher R., Biernat, Wojciech, Ryś, Janusz, Marszalek, Andrzej, Hoang, Mai P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290913/ https://www.ncbi.nlm.nih.gov/pubmed/32380691 http://dx.doi.org/10.3390/cells9051135

Ejemplares similares

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas
por: Wróblewska, Joanna P., et al.
Publicado: (2021)

Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles
por: Donizy, Piotr, et al.
Publicado: (2021)

Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas
por: Donizy, Piotr, et al.
Publicado: (2021)

Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

The Prognostic Values of PARP-1 Expression in Uveal Melanoma
por: Gajdzis, Malgorzata, et al.
Publicado: (2021)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

Correlation Between PARP-1 Immunoreactivity and Cytomorphological Features of Parthanatos, a Specific Cellular Death in Breast Cancer Cells
por: Donizy, P., et al.
Publicado: (2013)

PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1
por: Dziaman, Tomasz, et al.
Publicado: (2014)

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma
por: Koczkowska, Magdalena, et al.
Publicado: (2017)

The HSF1–PARP13–PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
por: Fujimoto, Mitsuaki, et al.
Publicado: (2017)

The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023)
por: Sznurkowski, Jacek J., et al.
Publicado: (2023)

PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma—A Clinical and an In Vitro Study
por: Kupczyk, Piotr, et al.
Publicado: (2021)

Activity of MCPIP1 RNase in tumor associated processes
por: Miekus, Katarzyna, et al.
Publicado: (2019)

Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma
por: Pośpiech, Ewelina, et al.
Publicado: (2015)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

Mucinous breast cancer – clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002
por: Sas-Korczyńska, Beata, et al.
Publicado: (2014)

MCPIP1 contributes to clear cell renal cell carcinomas development
por: Ligeza, Janusz, et al.
Publicado: (2017)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Are PARPs promiscuous?
por: Feijs, Karla L.H., et al.
Publicado: (2022)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
por: Maluchenko, Natalya, et al.
Publicado: (2022)

Osteosarcoma of the larynx
por: Sawicki, Piotr, et al.
Publicado: (2015)

Complex Structural Effects in Deformed High-Manganese Steel
por: Kowalska, Joanna, et al.
Publicado: (2021)

Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023)

Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023)

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
por: Inaguma, Shingo, et al.
Publicado: (2017)

Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al
por: Rys, Andrzej, et al.
Publicado: (2022)

Post-Irradiation Bladder Syndrome After Radiotherapy of Malignant Neoplasm of Small Pelvis Organs: An Observational, Non-Interventional Clinical Study Assessing VESIcare(®)/Solifenacin Treatment Results
por: Jaszczyński, Janusz, et al.
Publicado: (2016)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma
por: Inaguma, Shingo, et al.
Publicado: (2023)

ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells
por: Roper, Stephen J., et al.
Publicado: (2014)

Uncoupling of PARP1 Trapping and Inhibition Using Selective PARP1 Degradation
por: Wang, Shuai, et al.
Publicado: (2019)

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
por: Zuo, Hao, et al.
Publicado: (2020)

Dual function of HPF1 in the modulation of PARP1 and PARP2 activities
por: Kurgina, Tatyana A., et al.
Publicado: (2021)

ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
por: Li, Lili, et al.
Publicado: (2021)

Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Prokhorova, Evgeniia, et al.
Publicado: (2021)

PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
por: Đukić, Nina, et al.
Publicado: (2023)

PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1
por: Langelier, Marie-France, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d2kfe2h7oius2ubparm4b808r6